Recruiting studies: Malaria Falciparum

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

DON in Pediatric Cerebral Malaria
Phase 1/Phase 2 · 2 location(s) · Douglas Postels, MD, MS · NCT05478720 Field Trial of PfSPZ-LARC2 Vaccine in Burkinabe Adults
Phase 2 · 1 location(s) · Sanaria Inc. · NCT07385287 Assessing the Feasibility of Combining Dihydroartemisinin Piperaquine and Primaquine for Malaria Mass Drug Administratio
NA · 1 location(s) · Noguchi Memorial Institute for Medical Research · NCT07389057 Safety and Efficacy of Imatinib in Combination With Artemether-Lumefantrine for Uncomplicated Malaria
Phase 2 · 1 location(s) · Victoria Biomedical Research Institute · NCT07559370 Malaria Molecular Surveillance in Mozambique (Phase 2)
Phase N/A · 1 location(s) · Centro de Investigacao em Saude de Manhica · NCT06529237 Drug-Interaction Assessment of GSK3772701 in Healthy Male and Female Participants Aged 18 to 55 Years
Phase 1 · 1 location(s) · GlaxoSmithKline · NCT07670377 PfSPZ-LARC2 Vaccine in Women of Child-bearing Potential (WOCBP) in Mali
Phase 2 · 1 location(s) · Sanaria Inc. · NCT07675785 Mass Vaccine and Drug Administration, Bangladesh
Phase 4 · 2 location(s) · University of Oxford · NCT06068530 A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 Combined With R21/Matrix-M (a "Multi-stage" Malaria V
Phase 1 · 1 location(s) · University of Oxford · NCT06958198 Safety, Tolerability and Efficacy of PfSPZ-LARC2 Vaccine Against CHMI in Malaria-Naïve Adults
Phase 1 · 1 location(s) · Sanaria Inc. · NCT06862453 Platelet-Directed Whole Blood Transfusion Strategy for Malaria
NA · 2 location(s) · Johns Hopkins Bloomberg School of Public Health · NCT05711485 Infant Malaria Vaccine Schedule Optimization
Phase 2 · 2 location(s) · PATH · NCT06879327 A Study to Assess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 Months
Phase 2 · 2 location(s) · GlaxoSmithKline · NCT07036159 Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Fal
Phase 2 · 12 location(s) · Novartis Pharmaceuticals · NCT05750628 Dose Finding Trial of R21/Matrix-M in School Children
Phase 2 · 1 location(s) · University of Oxford · NCT07074665 Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of LAI MMV055 Alone and in Combinati
Phase 1 · 1 location(s) · Medicines for Malaria Venture · NCT07011511 A Study to Test Experimental Blood Stage Malaria Vaccine in Burkina Faso.
Phase 1/Phase 2 · 1 location(s) · University of Oxford · NCT05790889 Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar
Phase 3 · 2 location(s) · London School of Hygiene and Tropical Medicine · NCT06923592 Laboratory Evaluation of Pregnancy Malaria Vaccine Candidates/In-vitro Testing of Pregnancy Malaria Vaccine Candidates
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT02471378 A Study to Find Out if a Combination of 3 Medicines for the Treatment of Malaria Works as Well and is as Safe and Tolera
Phase 3 · 1 location(s) · University of Oxford · NCT05951595 An Observational Study to Assess Effectiveness and Safety of The R21/Matrix-M Malaria Vaccine
Phase N/A · 5 location(s) · Serum Institute of India Pvt. Ltd. · NCT07009847

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.